Pfizer sells Sandwich site
Pfizer has finally found a buyer for its Sandwich site in Kent, having completed the sale to a private consortium. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/pfizer_sells_sandwich_site_976851Pfizer has finally found a buyer for its Sandwich site in Kent, having completed the sale to a private consortium. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/pfizer_sells_sandwich_site_976851The UK’s Skyepharma says that partner Mundipharma has commenced an international clinical trial of the firms’ asthma drug Flutiform for the treatment of chronic obstructive pulmonary disease. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/skyepharmas_flutiform_in_copd_trials_1005720FDA employees return to work - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/fda_employees_return_to_work_1005871GlaxoSmithKline and partner Theravance are celebrating after the European Commission granted marketing authorisation for their chronic obstructive pulmonary disease Anoro. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/europe_approval_for_gsktheravance_copd_drug_1001914Genmab and partner Johnson & Johnson have been boosted by positive mid-stage data on daratumumab for multiple myeloma. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/genmab_multiple_myeloma_drug_shines_in_phase_ii_970988Ireland-based clinical research organisation giant Icon has completed its $143.5 million acquisition of Aptiv Solutions. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/icon_seals_acquisition_of_aptiv_1001917The European Commission has given the green light to Baxter International and Halozyme Therapeutics' HyQvia as replacement therapy for adults with primary and secondary immunodeficiencies. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/europe_approves_baxterhalozymes_hyqvia_1005059UCB has acquired the key pharmaceutical assets of the UK's Lectus Therapeutics, boosting its efforts in the central nervous system field. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/ucb_acquires_lectus_assets_980012It has been reported by Bloomberg that Pharmacyclics, which discovered the cancer drug Imbruvica, is looking for buyers and partner Johnson & Johnson and Novartis are cited as possible acquirers. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/pharmacyclics_up_for_sale_bloomberg_971114The UK's Acacia Pharma has raised £15 million to finance late-stage development of its treatments designed to prevent nausea and vomiting in cancer patients. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/acacia_raises_15_million_1005626